ConductScience.org, home

Paper33780970

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.

Cele S and 22 others. Nature, 2021. Cited by 511 papers, by iCite.

Cite this record

ConductScience Library. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Papers, record 33780970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33780970

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.
PubMed
Journal
Nature
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
511
iCite
Relative citation ratio, by iCite
23.2
iCite
Revised in PubMed
2026-05-18
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cele SSandile
2Gazy IInbal
3Jackson LLaurelle
4Hwa SHShi-Hsia
5Tegally HHouriiyah
6Lustig GGila
7Giandhari JJennifer
8Pillay SSureshnee
9Wilkinson EEduan
10Naidoo YYeshnee
11Karim FFarina
12Ganga YYashica
13Khan KKhadija
14Bernstein MMallory
15Balazs ABAlejandro B
16Gosnell BIBernadett I
17Hanekom WWillem
18Moosa MSMahomed-Yunus S
19Network for Genomic Surveillance in South AfricaGroup
20COMMIT-KZN TeamGroup

Source PubMed

See all 23 authorsDownload CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
Antibodies, ViralMajor topic
COVID-19Major topic
Immune EvasionMajor topic
MutationMajor topic
SARS-CoV-2Major topic
Animals
Cell Line
Chlorocebus aethiops
Humans
Immunization, Passive
Neutralization Tests
South Africa
Time Factors
Vero Cells
COVID-19 Serotherapy

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DP2 DA040254NIDA NIH HHSUnited StatesDP2DA040254PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133112236Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.Elife2020https://conductscience.org/library/papers/33112236PubMed
233690265Detection of a SARS-CoV-2 variant of concern in South Africa.Nature2021https://conductscience.org/library/papers/33690265PubMed
333654292SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.Nat Med2021https://conductscience.org/library/papers/33654292PubMed
433592168Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.Cell Host Microbe2021https://conductscience.org/library/papers/33592168PubMed
534417349SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34417349PubMed
633558724Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.Nat Med2021https://conductscience.org/library/papers/33558724PubMed
733853970Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.Science2021https://conductscience.org/library/papers/33853970PubMed
833567448mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.Nature2021https://conductscience.org/library/papers/33567448PubMed
933461210Evolution of antibody immunity to SARS-CoV-2.Nature2021https://conductscience.org/library/papers/33461210PubMed
1033259788Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition.Cell Host Microbe2021https://conductscience.org/library/papers/33259788PubMed
1121849975Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy.Nature2011https://conductscience.org/library/papers/21849975PubMed
1233761326N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.Cell2021https://conductscience.org/library/papers/33761326PubMed
1332540904Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.Science2020https://conductscience.org/library/papers/32540904PubMed
1433684280Neutralizing Activity of BNT162b2-Elicited Serum.N Engl J Med2021https://conductscience.org/library/papers/33684280PubMed
1518552857Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs.Nat Med2008https://conductscience.org/library/papers/18552857PubMed
1633535027Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization.Cell Host Microbe2021https://conductscience.org/library/papers/33535027PubMed
1733772244Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.Nat Med2021https://conductscience.org/library/papers/33772244PubMed
1832838945Growth, detection, quantification, and inactivation of SARS-CoV-2.Virology2020https://conductscience.org/library/papers/32838945PubMed
1933930298Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Cell2021https://conductscience.org/library/papers/33930298PubMed
2033730471Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.N Engl J Med2021https://conductscience.org/library/papers/33730471PubMed

See all 25 referencesDownload CSV of references

Cited by413

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 511 citations.

PMIDTitleJournalYearIn PapersSource
42643508Comparative systemic pathogenicity and host tropism of ancestral SARS-CoV-2, Delta, and Omicron EG.5 variants in K18-hACE2 mice.Front Immunol2026https://conductscience.org/library/papers/42643508PubMed
42385611Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.EBioMedicine2026https://conductscience.org/library/papers/42385611PubMed
41979069Serology survey against multiple SARS-CoV-2 variants of residents in Tainan, Taiwan.Virulence2026https://conductscience.org/library/papers/41979069PubMed
41912532Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial.NPJ Vaccines2026https://conductscience.org/library/papers/41912532PubMed
41884606Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant.Virus Evol2026https://conductscience.org/library/papers/41884606PubMed
41693861A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41693861PubMed
41688712Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort.Commun Med (Lond)2026https://conductscience.org/library/papers/41688712PubMed
41685161A novel fusion protein of COVID-19 virus enhancing protection of Syrian hamsters infected with SARS-CoV-2.Acta Pharm Sin B2026https://conductscience.org/library/papers/41685161PubMed
41301456Modeling the Mutational Effects on Biochemical Phenotypes of SARS-CoV-2 Using Molecular Fields.Biomolecules2025https://conductscience.org/library/papers/41301456PubMed
41258470A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023.Commun Med (Lond)2025https://conductscience.org/library/papers/41258470PubMed
40740485SARS-CoV-2 vaccines elicit differential Fc effector functions.iScience2025https://conductscience.org/library/papers/40740485PubMed
40434113The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells.mSphere2025https://conductscience.org/library/papers/40434113PubMed
40431733Evolution of Antiviral Drug Resistance in SARS-CoV-2.Viruses2025https://conductscience.org/library/papers/40431733PubMed
40205144Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus.Infect Dis Ther2025https://conductscience.org/library/papers/40205144PubMed
40133357Nightlife and low immunity drove transmission of SARS-CoV-2 gamma in Luxembourg, 2021.Sci Rep2025https://conductscience.org/library/papers/40133357PubMed
40040708Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19.Front Immunol2025https://conductscience.org/library/papers/40040708PubMed
40020259Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial.EBioMedicine2025https://conductscience.org/library/papers/40020259PubMed
39953108Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern.Sci Rep2025https://conductscience.org/library/papers/39953108PubMed
39936889Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale.Biotechnol Bioeng2025https://conductscience.org/library/papers/39936889PubMed
39873888Pharmacoinformatics-based screening and construction of a neutralizing anti-SARS-CoV-2 camelidae nanobody drug conjugate.Mol Divers2025https://conductscience.org/library/papers/39873888PubMed

See all 413 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
EEF1A21917PubTator's text mininghttps://conductscience.org/library/genes/1917NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33780970

GET https://conductscience.org/api/papers/v1/33780970/authors?page=2